Enhancement of SMN protein levels in a mouse model of spinal muscular atrophy using novel drug-like compounds

Spinal muscular atrophy (SMA) is a neurodegenerative disease that causes progressive muscle weakness, which primarily targets proximal muscles. About 95% of SMA cases are caused by the loss of both copies of the SMN1 gene. SMN2 is a nearly identical copy of SMN1, which expresses much less functional...

Descripción completa

Detalles Bibliográficos
Autores principales: Cherry, Jonathan J, Osman, Erkan Y, Evans, Matthew C, Choi, Sungwoon, Xing, Xuechao, Cuny, Gregory D, Glicksman, Marcie A, Lorson, Christian L, Androphy, Elliot J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721476/
https://www.ncbi.nlm.nih.gov/pubmed/23740718
http://dx.doi.org/10.1002/emmm.201202305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721476/
https://www.ncbi.nlm.nih.gov/pubmed/23740718
http://dx.doi.org/10.1002/emmm.201202305

Ejemplares similares